1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Genetic Testing Market Outlook 2020

Genetic Testing Market Outlook 2020

  • June 2015
  • -
  • RNCOS
  • -
  • 135 pages

The term ‘Genetic Testing’ refers to tests performed on DNA and RNA samples collected from patients. The so called ‘predictive tests’ give scientists and medical professionals vital clues to how an individual may develop a disease. These innovative tests can assess the risk of onset of a specific disease (genetic) based on the mutated genetic code even before the disease is symptomatic. Today, Genetic Testing is entitled as one of the fastest evolving segments of the molecular diagnostics market. Supported by factors such as growing incidences of chronic diseases, surging awareness for chromosomal abnormalities among pregnant women, and intensive R&D expenditures, the market for genetic testing is showing an impressive growth worldwide.

RNCOS’ analysts have predicted that the Global Genetic Testing market will grow at a CAGR of 10% during the forecasted period 2014-2020. The new edition of the report “Genetic Testing Market Outlook 2020”, highlights the market landscape, key contributing drivers of the market, emerging sectors, and the regulatory framework surrounding the genetic testing segment. The report is an outcome of an in-depth market analysis by our team of analysts. It also covers the application aspect of genetic tests in several therapeutic areas, as well as the list of genetic tests available in the market.

The research effectively illustrates the growth of Genetic Testing in both developed and developing countries. There is a comprehensive analytics too of key developments in major markets including the US, Europe and Asian countries. A country level analysis depicts the level of penetration of genetic testing, types of tests available, consumer perspectives, and future growth.

Key vendors influencing the industry include Abbott, Roche, Siemens, Illumina, Thermo Fischer Scientific, and Myriad Genetics among others. The report analyzes a competitive landscape of the market by properly analyzing the business, services and activities of the companies along with their SWOT analysis. Overall, the latest edition provides a comprehensive overview of the global genetic testing market, which will enable clients and investors to frame a successful business strategy to enter the Billion dollar industry.

Table Of Contents

Genetic Testing Market Outlook 2020
1. Analyst View
2. Research Methodology
3. Genetic Testing Overview
3.1 Application and Advantages
3.2 Methods
4. Global Genetic Testing Market Overview
4.1 Market Outlook
4.2 Genetic Testing Laboratories - Unmet Need Analysis
4.3 Direct-to-Consumer (DTC) Genetic Testing
5. Drivers and Challenges
5.1 Drivers
5.1.1 Increasing Public Awareness for Genetic Tests
5.1.2 Rising Incidence of Chronic Diseases
5.1.3 Growth in Ageing Population
5.2 Challenges
5.2.1 Decline in Fertility Rates
5.2.2 Ethical and Policy Issues
6. Disease-Wise Analysis
6.1 Alzheimer's Disease
6.2 Cystic Fibrosis
6.3 Cancer
6.4 Bloom Syndrome
7. Country-Level Analysis
7.1 US
7.1.1 Market Overview
7.1.2 Recent Developments
7.2 Europe
7.2.1 Market Overview
7.2.2 Recent Developments
7.3 Asia-Pacific
7.3.1 Market Overview
7.3.2 Recent Developments
8. Emerging Sectors
8.1 Next-Generation Sequencing (NGS)
8.2 Non-Invasive Prenatal Testing (NIPT)
8.3 Whole Genome Sequencing (WGS) for Cancer
8.4 Personalized Medicine
9. Genetic Testing Regulation
10. Competitive Assessment
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Product Offering
10.1.3 Key Financials
10.1.4 Recent Developments
10.1.5 Strengths and Weaknesses
10.2 Roche Diagnostics
10.2.1 Company Overview
10.2.2 Product Offering
10.2.3 Key Financials
10.2.4 Recent Developments
10.2.5 Strengths and Weaknesses
10.3 Myriad Genetics, Inc.
10.3.1 Company Overview
10.3.2 Product Offering
10.3.3 Key Financials
10.3.4 Recent Developments
10.3.5 Strengths and Weaknesses
10.4 Thermo Fisher Scientific
10.4.1 Company Overview
10.4.2 Product Offering
10.4.3 Key Financials
10.4.4 Recent Developments
10.4.5 Strengths and Weaknesses
10.5 Agilent Technologies Inc.
10.5.1 Company Overview
10.5.2 Product Offering
10.5.3 Key Financials
10.5.4 Recent Development
10.5.5 Strengths and Weaknesses
10.6 Hologic, Inc.
10.6.1 Company Overview
10.6.2 Product Offering
10.6.3 Key Financials
10.6.4 Recent Developments
10.6.5 Strengths and Weaknesses
10.7 Illumina, Inc.
10.7.1 Company Overview
10.7.2 Product Offering
10.7.3 Key Financials
10.7.4 Recent Developments
10.7.5 Strengths and Weaknesses
10.8 Qiagen NV
10.8.1 Company Overview
10.8.2 Product Offering
10.8.3 Key Financials
10.8.4 Recent Developments
10.8.5 Strengths and Weaknesses
10.9 Cepheid
10.9.1 Company Overview
10.9.2 Product Offering
10.9.3 Key Financials
10.9.4 Recent Developments
10.9.5 Strengths and Weaknesses
10.10 Affymetrix, Inc.
10.10.1 Company Overview
10.10.2 Product Offering
10.10.3 Key Financials
10.10.4 Recent Developments
10.10.5 Strength and Weaknesses

List of Figures:

Figure 4-1: Genetic Testing Market (Billion US$), 2014-2020
Figure 4-2: Genetic Testing Market by Geography (%), 2014
Figure 4-3: Genetic Testing Market by Geography (%), 2020
Figure 7-1: Number of Disorders, Genes, Labs, and Clinics for Genetic Testing (2014 and 2015)
Figure 7-2: Number of Genetic Tests Performed (2013-2015)
Figure 7-3: US - Genetic Testing Market (Billion US$), 2014-2020
Figure 7-4: Europe - Genetic Testing Market (Billion US$), 2014-2020
Figure 7-5: Asia-Pacific - Genetic Testing Market (Million US$), 2014-2020
Figure 8-1: Global - Next Generation Sequencing Market (Billion US$), 2014-2020
Figure 8-2: Global - NGS Application by Sector (%)
Figure 8-3: Global - Next Generation Sequencing Market by Player (%), 2013
Figure 8-4: Global - Non-Invasive Prenatal Testing Market (Million US$), 2014-2020
Figure 8-5: US - Tapped and Untapped Personalized Cancer WGS Market (%), 2013
Figure 8-6: US - Personalized Cancer WGS Market (Million US$), 2014-2020
Figure 8-7: Organizational Transformation to Support Personalized Medicine
Figure 9-1: Genetic Testing Regulatory Agencies
Figure 10-1: Abbott Laboratories - Revenue Breakup by Segments (%), 2014
Figure 10-2: Abbott Laboratories - Revenue Breakup by Geography (%), 2014
Figure 10-3: Roche Holding - Revenue Breakup by Segments (%), 2014
Figure 10-4: Roche Holding - Diagnostic Division Revenue by Geography (%), 2014
Figure 10-5: Myriad Genetics - Revenue Breakup by Segments (%), 2014
Figure 10-6: Life Technologies - Revenue Breakup by Segments (%), 2014
Figure 10-7: Life Technologies - Revenue Breakup by Geography (%), 2014
Figure 10-8: Agilent - Revenue Breakup by Segments (%), 2014
Figure 10-9: Hologic - Revenue Breakup by Segments (%), 2014
Figure 10-10: Hologic - Revenue Breakup by Geography (%), 2014
Figure 10-11: Illumina - Revenue Breakup by Geography (%), 2014
Figure 10-12: Qiagen NV - Revenue Break up by Segments (%), 2014
Figure 10-13: Qiagen NV - Revenue Break up by Geography (%), 2014
Figure 10-14: Cepheid - Revenue Break up by Segments (%), 2014
Figure 10-15: Cepheid - Revenue Break up by Geography (%), 2014
Figure 10-16: Affymetrix - Revenue Breakup by Segments (%), 2014
Figure 10-17: Affymetrix - Revenue Breakup by Geography (%), 2014

List of Tables:

Table 4-1: Key DTC Genetic Testing Companies by Category
Table 4-2: Key Test Areas Offered in DTC Genetic Testing Segment
Table 7-1: FDA Approved Pharmacogenomic Biomarkers for Oncology
Table 9-1: Abbott Laboratories - Key Gene Based Products
Table 9-2: Abbott Laboratories - Financial Performance (Million US$), 2012-2014
Table 9-3: Roche Molecular Diagnostics - Key Gene Based Products
Table 9-4: Roche Holding - Financial Performance (Million US$), 2012-2014
Table 9-5: Myriad Genetics - Key Gene Based Products
Table 9-6: Myriad Genetics - Financial Performance (Million US$), 2012-2014
Table 9-7: Life Technologies - Key Gene Based Products
Table 9-8: Life Technologies - Financial Performance (Million US$), 2012-2014
Table 9-9: Agilent - Key Gene Based Products
Table 9-10: Agilent - Financial Performance (Million US$), 2012-2014
Table 9-11: Hologic - Key Gene Based Products
Table 9-12: Hologic - Financial Performance (Million US$), 2012-2014
Table 9-13: Illumina - Key Gene Based Products
Table 9-14: Illumina - Financial Performance (Million US$), 2012-2014
Table 9-15: Qiagen NV - Key Gene Based Products
Table 9-16: Qiagen NV - Financial Performance (Million US$), 2012-2014
Table 9-17: Cepheid - Key Gene Based Products
Table 9-18: Cepheid - Financial Performance (Million US$), 2012-2014
Table 9-19: Affymetrix - Key Gene Based Products
Table 9-20: Affymetrix - Financial Performance (Million US$), 2012-2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The global predictive genetic testing & consumer/wellness genomics market is anticipated to reach USD 4.6 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing ...

Global Genetic Testing Market

Global Genetic Testing Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global e-Health market is estimated at USD 124 billion in 2016 and is projected to reach USD 244 billion by 2021, growing at a CAGR of 14.56% during the forecast period. Despite, decades of effort ...

Global Genetic Testing Market Analysis & Trends - Industry Forecast to 2025

Global Genetic Testing Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • January 2017
  • by Accuray Research LLP

The Global Genetic Testing Market is poised to grow at a CAGR of around 10.4% over the next decade to reach approximately $10.3 billion by 2025. Some of the prominent trends that the market is witnessing ...

Europe Genetic Testing Market

December 2016 $ 3850

Download Unlimited Documents from Trusted Public Sources

MicroRNA Industry in China and New Caledonia

  • February 2017
    18 pages
  • microRNA  

  • China  

    New Caledonia  

View report >

Psychotic Disorder Statistics in the UK

  • February 2017
    5 pages
  • Psychotic Disor...  

  • United Kingdom  

View report >

Cytogenetic Industry in the US

  • February 2017
    6 pages
  • Cytogenetic  

  • United States  

View report >

Dna Industry

2 days ago

Cancer Statistics

10 days ago

Related Market Segments :

Genetic

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.